YU94802A - 3-prolekovi 2'-deoksi-beta-l-nukleozida - Google Patents

3-prolekovi 2'-deoksi-beta-l-nukleozida

Info

Publication number
YU94802A
YU94802A YU94802A YUP94802A YU94802A YU 94802 A YU94802 A YU 94802A YU 94802 A YU94802 A YU 94802A YU P94802 A YUP94802 A YU P94802A YU 94802 A YU94802 A YU 94802A
Authority
YU
Yugoslavia
Prior art keywords
nucleosides
deoxy
prodrugs
beta
hepatitis
Prior art date
Application number
YU94802A
Other languages
English (en)
Inventor
Martin L. Bryant
Giles Gosselin
Jean-Louis Imbach
Original Assignee
Idenix (Cayman) Limited
Centre National Da La Recherche Scientifique (Cnrs)
L'universite Montpellier Ii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idenix (Cayman) Limited, Centre National Da La Recherche Scientifique (Cnrs), L'universite Montpellier Ii filed Critical Idenix (Cayman) Limited
Publication of YU94802A publication Critical patent/YU94802A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Ovaj pronalazak se odnosi na jedinjenja, smeše i metode lečenja domaćina zaraženog hepatitis B virusom. Posebno, izložena su jedinjenja smeše 3'-estra 2'- deoksi-ГЎ-L-nukleozida, koja se mogu primeniti bilo sama bilo u kombinaciji sa drugim anti-hepatitis B-agensima. Opisana su jedinjenja i smeše 3',5'-estara 2'-deoksi-ГЎ-L-nukleozida, koja se mogu primeniti bilo sama bilo u kombinaciji sa drugim anti-hepatitis B agensima.[The present invention relates to compounds, compositions and methods for the treatment of a host infected with a hepatitis B virus. Specifically, compounds and compositions of 3'-esters of 2'-deoxy-ГЎ-L-nucleosides are disclosed, which can be administered either alone or in combination with other anti-hepatitis B agents. Compounds and compositions of 3',5'-esters of 2'-deoxy-ГЎ-L-nucleosides are disclosed, which can be administered either alone or in combination with other anti-hepatitis B agents, are also disclosed.
YU94802A 2000-06-15 2001-06-15 3-prolekovi 2'-deoksi-beta-l-nukleozida YU94802A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21210000P 2000-06-15 2000-06-15

Publications (1)

Publication Number Publication Date
YU94802A true YU94802A (sh) 2006-03-03

Family

ID=22789563

Family Applications (1)

Application Number Title Priority Date Filing Date
YU94802A YU94802A (sh) 2000-06-15 2001-06-15 3-prolekovi 2'-deoksi-beta-l-nukleozida

Country Status (27)

Country Link
EP (1) EP1296995B1 (sh)
JP (1) JP4639032B2 (sh)
KR (2) KR20070048277A (sh)
CN (3) CN1900104A (sh)
AP (1) AP1771A (sh)
AR (1) AR035711A1 (sh)
AT (1) ATE411332T1 (sh)
AU (2) AU6692701A (sh)
BR (1) BR0111732A (sh)
CA (1) CA2413163C (sh)
CZ (1) CZ2003122A3 (sh)
DE (1) DE60136181D1 (sh)
EA (1) EA005774B1 (sh)
ES (1) ES2317912T3 (sh)
IL (3) IL153379A0 (sh)
MA (1) MA27126A1 (sh)
MX (1) MXPA02012443A (sh)
MY (1) MY141594A (sh)
NO (1) NO20026001L (sh)
NZ (2) NZ523632A (sh)
OA (1) OA12384A (sh)
PE (1) PE20020216A1 (sh)
PL (1) PL360404A1 (sh)
UY (1) UY26779A1 (sh)
WO (1) WO2001096353A2 (sh)
YU (1) YU94802A (sh)
ZA (2) ZA200300168B (sh)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0110023A (pt) 2000-04-13 2003-12-30 Pharmasset Ltd Derivados de nucleosìdeo 3'-ou-2' substituìdos para tratamento de infecções por vìrus da hepatite
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
US6787526B1 (en) 2000-05-26 2004-09-07 Idenix Pharmaceuticals, Inc. Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
EA007867B1 (ru) 2000-05-26 2007-02-27 Айденикс (Кайман) Лимитед Композиции для лечения флавивирусных и пестивирусных инфекций и способы их применения
CN103319554A (zh) 2002-06-28 2013-09-25 埃迪尼克斯医药公司 用于治疗黄病毒感染的修饰的2’和3’-核苷前药
WO2004003000A2 (en) 2002-06-28 2004-01-08 Idenix (Cayman) Limited 1’-, 2'- and 3'- modified nucleoside derivatives for treating flaviviridae infections
AP2005003213A0 (en) 2002-06-28 2005-03-31 Univ Cagliari 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections.
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
KR100855907B1 (ko) 2002-09-13 2008-09-02 노파르티스 아게 내성 ＨＢＶ 균주 치료용 β-Ｌ-2'-데옥시뉴클레오시드 및병용 요법
US7824851B2 (en) 2002-11-15 2010-11-02 Idenix Pharmaceuticals, Inc. 2′-branched nucleosides and Flaviviridae mutation
CN101415719A (zh) 2003-03-20 2009-04-22 微生物化学及药品有限公司 生产2’-脱氧-β-L-核苷的方法
CN1812995A (zh) * 2003-04-28 2006-08-02 艾登尼科斯（开曼）有限公司 工业化规模的核苷合成
EP2345659A1 (en) 2003-05-30 2011-07-20 Pharmasset, Inc. Modified fluorinated nucleoside analogues
EP1639121A4 (en) 2003-06-30 2008-04-16 Idenix Cayman Ltd SYNTHESIS OF BETA-L-2-DESOXYNUCLEOSIDES
CN1980657A (zh) 2004-05-05 2007-06-13 耶鲁大学 新颖的抗病毒赛菊宁黄质类似物
EP1809301B1 (en) 2004-09-14 2019-11-06 Gilead Pharmasset LLC 2-fluoro-2-alkyl-substituted d-ribonolactone intermediates
US7524831B2 (en) 2005-03-02 2009-04-28 Schering Corporation Treatments for Flaviviridae virus infection
ATE524183T1 (de) 2005-06-17 2011-09-15 Novartis Ag Verwendung von sanglifehrin bei der hcv-therapie
GB0609178D0 (en) 2006-05-09 2006-06-21 Univ Cardiff Novel compounds
US7897737B2 (en) 2006-12-05 2011-03-01 Lasergen, Inc. 3′-OH unblocked, nucleotides and nucleosides, base modified with photocleavable, terminating groups and methods for their use in DNA sequencing
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
TW200946541A (en) 2008-03-27 2009-11-16 Idenix Pharmaceuticals Inc Solid forms of an anti-HIV phosphoindole compound
JP5143953B2 (ja) 2008-06-11 2013-02-13 レーザーゲン インコーポレイテッド ヌクレオチドおよびヌクレオシドならびにｄｎａ配列決定におけるその使用の方法
US8551973B2 (en) 2008-12-23 2013-10-08 Gilead Pharmasset Llc Nucleoside analogs
US8716262B2 (en) 2008-12-23 2014-05-06 Gilead Pharmasset Llc Nucleoside phosphoramidates
SG194404A1 (en) 2008-12-23 2013-11-29 Gilead Pharmasset Llc Synthesis of purine nucleosides
TWI576352B (zh) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
CN104017020B (zh) 2010-03-31 2017-04-12 吉利德制药有限责任公司 核苷氨基磷酸酯
JP2013523765A (ja) 2010-04-01 2013-06-17 イデニク プハルマセウティカルス，インコーポレイテッド ウイルス感染の治療のための化合物及び医薬組成物
WO2012075140A1 (en) 2010-11-30 2012-06-07 Pharmasset, Inc. Compounds
CA2843324A1 (en) 2011-03-31 2012-11-15 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of viral infections
US8951985B2 (en) 2011-09-12 2015-02-10 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of viral infections
EP3670523B1 (en) 2011-09-13 2021-08-11 Agilent Technologies, Inc. 3'-oh unblocked, fast photocleavable terminating nucleotides and their use in methods for nucleic acid sequencing
HUE036588T2 (hu) 2011-09-16 2018-07-30 Gilead Pharmasset Llc Eljárások HCV kezelésére
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
AR090699A1 (es) * 2012-04-18 2014-12-03 Biocryst Pharm Inc Compuestos inhibidores de la actividad de la arn polimerasa viral
LT2950786T (lt) 2013-01-31 2020-03-10 Gilead Pharmasset Llc Dviejų antivirusinių junginių preparatų kompozicija
NZ716840A (en) 2013-08-27 2017-06-30 Gilead Pharmasset Llc Combination formulation of two antiviral compounds
MX2020010667A (es) 2018-04-12 2021-01-08 Modis Therapeutics Inc Profarmacos de desoxinucleosidos para el tratamiento de enfermedades causadas por reservas desequilibradas de nucleotidos.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4958013A (en) * 1989-06-06 1990-09-18 Northwestern University Cholesteryl modified oligonucleotides
IT1246983B (it) * 1990-11-13 1994-12-12 Consiglio Nazionale Ricerche L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
US5559101A (en) * 1994-10-24 1996-09-24 Genencor International, Inc. L-ribofuranosyl nucleosides
SE505648C2 (sv) * 1996-08-30 1997-09-22 Scania Cv Ab Anordning vid ett fordon för monterbar anfästning av en förarplatsmodul
DK1104436T3 (da) * 1998-08-10 2006-04-03 Centre Nat Rech Scient Beta-L-2'-deoxy-nukleosider til behandling af hepatitis B-virus

Also Published As

Publication number Publication date
OA12384A (en) 2006-04-17
EP1296995A2 (en) 2003-04-02
BR0111732A (pt) 2003-06-24
ES2317912T3 (es) 2009-05-01
CA2413163A1 (en) 2001-12-20
NZ523632A (en) 2005-03-24
CN1900104A (zh) 2007-01-24
PE20020216A1 (es) 2002-04-16
JP4639032B2 (ja) 2011-02-23
IL153379A (en) 2007-02-11
AR035711A1 (es) 2004-07-07
KR20070048277A (ko) 2007-05-08
CN101012259A (zh) 2007-08-08
CA2413163C (en) 2008-11-18
EA005774B1 (ru) 2005-06-30
NZ535246A (en) 2006-06-30
MY141594A (en) 2010-05-14
ZA200404306B (en) 2005-06-15
AP2003002713A0 (en) 2003-03-31
NO20026001D0 (no) 2002-12-13
EP1296995B1 (en) 2008-10-15
EA200300023A1 (ru) 2003-08-28
NO20026001L (no) 2003-02-12
DE60136181D1 (de) 2008-11-27
JP2004533403A (ja) 2004-11-04
UY26779A1 (es) 2001-12-28
IL178864A0 (en) 2007-03-08
CN1295242C (zh) 2007-01-17
AU6692701A (en) 2001-12-24
CZ2003122A3 (cs) 2003-06-18
IL153379A0 (en) 2003-07-06
CN1452627A (zh) 2003-10-29
WO2001096353A2 (en) 2001-12-20
MXPA02012443A (es) 2004-09-10
ZA200300168B (en) 2004-07-07
MA27126A1 (fr) 2005-01-03
AU2001266927B2 (en) 2006-12-14
PL360404A1 (en) 2004-09-06
WO2001096353A3 (en) 2002-04-18
KR20030032967A (ko) 2003-04-26
ATE411332T1 (de) 2008-10-15
AP1771A (en) 2007-08-23

Similar Documents

Publication Publication Date Title
AP1771A (en) 3'-Prodrugs of 2'-deoxy-?-L-nucleosides.
TW200602350A (en) Methods and compositions for treating hepatitis C virus
EA200201263A1 (ru) СПОСОБЫ ЛЕЧЕНИЯ ИНФЕКЦИЙ, ВЫЗЫВАЕМЫХ ВИРУСОМ ГЕПАТИТА ДЕЛЬТА, С ИСПОЛЬЗОВАНИЕМ β-L-2'-ДЕЗОКСИНУКЛЕОЗИДОВ
RS100504A (en) Hepatitis c virus inhibitors
WO2003026589A3 (en) Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
EP1687018A4 (en) INHIBITORS OF HEPATITIS C VIRUS
WO2005054430A3 (en) Hepatitis c virus inhibitors
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
ES2165269A1 (es) Derivados de alfa-cetoamidas.
HK1068538A1 (en) Antiviral compounds
UA66767C2 (uk) Інгібітори серин-протеаз, фармацевтична композиція, спосіб інгібування активності та спосіб лікування або профілактики вірусної інфекції гепатиту с
ATE339211T1 (de) L-fmau zur behandlung von hepatitis-delta-virus- infizierung
MXPA02011969A (es) Metodos para el tratamiento de padecimientos virales con il-18 y combinaciones de il-18.
MD940152A (ro) Compoziţie farmaceutică pentru tratarea infecţiilor şi bolilor, provocate de virusul hepatitei V (HBV)
WO2003015714A3 (en) Compositions and therapeutic methods for viral infection
WO2003017943A3 (en) Therapeutic compositions and methods for treating viral infection
RS20120367A2 (en) METHODS AND MIXTURES FOR TREATMENT OF VIRAL HEPATITIS C
SG153666A1 (en) Treatment of hepatitis b virus infection with human monoclonal antibodies
AU2001270226A1 (en) Tolerance and chronic hepatitis c virus
UA37622A (uk) 1,5-піперидил - 3,7-біс/діетаноламіну/ - піримідил ізовалеріанат, що використовується для діагностики вірусних інфекцій